Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 10, Pages 2124-2132
Publisher
Springer Science and Business Media LLC
Online
2022-09-16
DOI
10.1038/s41591-022-02017-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
- (2022) Richard A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: advancing towards its implementation
- (2022) Agner R. Parra Sánchez et al. Nature Reviews Rheumatology
- GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany
- (2022) Wolfgang Andreas Bethge et al. BLOOD
- CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma
- (2021) Kai Rejeski et al. BLOOD
- CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
- (2021) Dimitrios Mougiakakos et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2021 DORIS definition of remission in SLE: final recommendations from an international task force
- (2021) Ronald F van Vollenhoven et al. Lupus Science & Medicine
- Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
- (2020) Xuexiao Jin et al. Cellular & Molecular Immunology
- Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
- (2020) Carlos A. Ramos et al. JOURNAL OF CLINICAL ONCOLOGY
- Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.
- (2020) M.-L. Schubert et al. ANNALS OF ONCOLOGY
- Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies
- (2020) Kevin R. Parker et al. CELL
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus
- (2020) David S. Pisetsky et al. Nature Reviews Rheumatology
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
- (2019) Martin Aringer et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus
- (2019) Pragnesh Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Longitudinal anti‐nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent‐onset disease
- (2019) M. Frodlund et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- The EURE-CART project as a prototype model for CAR T-cell immunotherapy in Europe
- (2018) Franco Locatelli et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus
- (2018) Mona H. C. Biermann et al. Frontiers in Immunology
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow
- (2015) H. E. Mei et al. BLOOD
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
- (2011) C.-S. Yee et al. RHEUMATOLOGY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95
- (2008) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started